BioAlberta News
Cyplasin Biomedical Ltd Secures $10M Equity Credit Line Financing

Cyplasin Biomedical is a product-oriented, specialty pharmaceutical company focused on developing products for the multi-billion dollar hepatitis C virus (HCV) market. The Company is pleased to announce it has secured US$10M in financing under an equity line of credit (ELOC) with Tangiers Investors, LP to fund the Company's operations and product development programs.

 
Wednesday, July 28, 2010 - 09:13
Law Firms Optimistic About Canada's Life Sciences Industry
Legal firms say Canada's life sciences industry will survive the current economic crunch and prosper, in spite of access to capital.
 

Read full press release details.

Friday, July 23, 2010 - 08:52
Ceapro Announces Completion of License and Distribution Agreement with Oat Cosmetics Ltd. for Sale of All-Natural Active Ingredients
Ceapro Inc. (TSX VENTURE: CZO.V) is pleased to announce today the completion of a new marketing partnership and distribution agreement with UK firm, Oat Cosmetics Ltd. The agreement encompasses all of Ceapro's current range of all-natural active ingredients.
 
Friday, July 16, 2010 - 15:04
Innovotech Receives Funding to Advance Environmentally Friendly Agricultural Crop Protection Product
June 30, 2010 - Innovotech Inc. (TSX VENTURE:IOT), a pioneer in the field of biofilm product development, has secured funding in excess of $900,000 from Agriculture and Agri-Food Canada to facilitate the commercialization of Agress™, its unique, environmentally friendly seed treatment and plant spray designed to protect crops against both bacterial and fungal infections.
 
Friday, July 16, 2010 - 15:01
BioMS Medical Corp. Becomes Medwell Capital Corp.

BioMS Medical Corp. shareholders approved a motion to change the company's name to Medwell Capital Corp. at the Company’s annual meeting held on 25 June 2010.

Read full details of press release.

 

Monday, July 12, 2010 - 09:40
Ceapro Announces Completion of License and Distribution Agreement with Oat Cosmetics Ltd. for Sale of All-Natural Active Ingredients in UK

CEAPRO Inc. announced the completion of a new marketing partnership and distribution agreement with UK firm, Oat Cosmetics Ltd. The agreement encompasses all of Ceapro's current range of all-natural active ingredients.

Read detail of press release here.

Thursday, June 24, 2010 - 15:23
SciMed Technologies Inc. Receive Certification of Worlds First Rapid Test for Vitamin A in Liquid Milk
SciMed Technologies Inc. announces they received certification from the AOAC International - a worldwide scientific association dedicated to analytical excellence - for VitaKit A(R) the world's first 2 hour rapid test for accurate analysis of vitamin A in liquid milk.
 
 
Thursday, June 10, 2010 - 14:04
Alberta Enterprise Announces Multi-Million $ Investments

Alberta Enterprise, a fund of funds manager investing in knowledge-based industries, investments brings leading clean energy venture capital firm to Alberta in and improves access to capital in information technology and clean tech sectors.

For details, follow links below:

Thursday, June 3, 2010 - 09:51
Abbott Laboratories Advance New Phase III Trial Drug Targeting MS
 

For more details, click here.

Wednesday, May 26, 2010 - 12:24
Stem Cell Therapeutics Stroke Drug Trial Fails to Achieve Statistical Significance

CALGARY, ALBERTA--(Marketwire - May 25, 2010) - Stem Cell Therapeutics Corp. ("SCT" or the "Company") (TSX VENTURE:SSS) announced today the top-line results for the modified REGENESIS-Phase IIb stroke trial. The modified REGENESIS- Phase IIb trial, a placebo controlled, double blinded, 3:1 randomized clinical study, enrolled 96 patients with acute ischemic stroke between August 2009 and January 24, 2010.

Wednesday, May 26, 2010 - 08:55